Monitor for any further C-suite departures or changes in commercial execution plans in upcoming quarters. The termination appears routine, but investors should watch for any signs of broader organizational upheaval.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 15 $12.82entry
- T+1 · 6mo ago +5.54%α +5.60% · $13.53
- T+5 · 6mo ago +16.73%α +15.77% · $14.97
- T+20 · 5mo ago +30.73%α +28.61% · $16.76
- T+60 · 3mo ago +82.84%α +78.32% · $23.44
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Tandem Diabetes terminated EVP and Chief Commercial Officer Mark Novara without cause, effective May 18, 2026. The company emphasizes that its strategy and 2026 goals remain unchanged, suggesting the departure is isolated rather than a broader restructuring signal.
Key Facts
- Mark Novara, EVP and Chief Commercial Officer, terminated without cause
- Last day of employment is May 18, 2026
- Company states strategy and 2026 goals remain unchanged
Financial Impact
No direct financial impact disclosed
Risk Factors
- Potential disruption to sales or commercial operations
- Further departures or organizational changes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001438133-26-000052 |
| Document: 0001438133-26-000052-index-headers.html | 0001438133-26-000052 |
| Document: 0001438133-26-000052-index.html | 0001438133-26-000052 |
| Document: 0001438133-26-000052.txt | 0001438133-26-000052 |
Track record
9 reports on TNDM
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $18.50 Now $18.48 +0.11% settles Nov 18
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $20.00 Now $18.48 −7.60% settles Nov 17
- Nov 13, 20263d ago 8-K Bullish 5/10 Entry $20.07 to $18.48 Now $18.48 −7.92% ▼ −7.92% −6.01% vs SPY
- Nov 9, 20267d ago SC 13G Neutral 4/10 Entry $18.71 to $18.77 Now $18.48 −1.23% ▲ +0.32% −1.00% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $16.91 to $18.17 Now $18.48 +9.28% ▲ +7.45% +5.08% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $19.68 to $19.79 Now $18.48 −6.10% ▲ +0.56% +0.94% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $15.80 to $16.60 Now $18.48 +16.96% ▲ +5.06% +4.52% vs SPY
- May 15, 202626w ago 8-K Neutral 3/10 Viewing Entry $12.82 to $13.53 Now $18.48 +44.15% ▲ +5.54% +5.60% vs SPY
- Apr 7, 202631w ago DEFA14A Neutral 3/10 Entry $19.35 to $19.68 Now $18.48 −4.50% ▲ +1.71% +1.13% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers